Chen Hong Jianping Wei Tao Zhou Xia Wang Jing Cai
10.2147/OTT.S364566
Onco Targets Ther
2022 Jun 10;15:651-657.
erc1 fgfr fusion ngs anlotinib lung adenocarcinoma
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/35712652/
Case Reports
PMC9196998
35712652
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
2022